Cramer's 'Mad Money' Recap: Ride NYSE-Euronext Success

It's time to back up the truck on NYX, he said.

Benefit of the Doubt II

In his new "Benefit of the Doubt" segment, Cramer told viewers that when it comes to consumer products and retail, people can't simply bank on monthly sales numbers. With the benefit of the doubt, market players can predict which CEOs will make their numbers and which will miss them, he said.

Even the best CEO misses the numbers sometimes, Cramer said, and he's here to tell people when the "miss" matters and when it shouldn't.

He added J.C. Penney's (JCP Quote) Myron Ullman to his BOD list.

Explaining the addition, Cramer said that on Feb. 22, J.C. Penney reported a quarter that Ullman wasn't happy with. However, the CEO told people not to worry and that the company would be back on track come March, Cramer said.

But market players didn't trust Ullman, and analysts downgraded the stock, sending it to $77 a share.

But now the stock is at $81, and the retailers numbers are coming in just as Ullman promised, Cramer said. If investors had trusted Ullman, they could have made some money, he said. Cramer believes that J.C. Penney is "headed for new highs," and he says that the next time it reports disappointing numbers, if Ullman says not to worry, then don't. Instead, buy the stock, Cramer said.